Medicare Enrolled
Dr. Ajit Maniam, M.D.
Optician · Anaheim, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Maniam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maniam?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Maniam
Dr. Ajit Maniam is an optician specialist in Anaheim, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Maniam performed 4,687 Medicare services across 1,239 unique beneficiaries.
Between the years covered by Open Payments, Dr. Maniam received a total of $10,363 from 78 pharmaceutical and/or device companies across 489 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Maniam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in CA
$10,363 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,687
Medicare services
Top 18% in CA for optician
1,239
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~234 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
924 | $0 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
794 | $105 | $200 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
741 | $8 | $45 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
724 | $8 | $10 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
431 | $102 | $150 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
210 | $26 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
125 | $123 | $400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
120 | $148 | $275 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
111 | $13 | $40 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
97 | $106 | $185 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
96 | $78 | $150 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
60 | $67 | $150 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
48 | $1 | $20 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
42 | $1 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
41 | $60 | $150 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
39 | $46 | $91 |
| New patient office visit, complex (60-74 min) | 36 | $182 | $382 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $158 | $260 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
17 | $21 | $75 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
12 | $174 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.0% high complexity
24.0% medium
68.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,363
Total received (2018-2024)
Avg $1,480/year across 7 years
Top 14% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
489
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,303 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$60 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,954
2023
$2,640
2022
$2,422
2021
$1,216
2020
$124
2019
$559
2018
$448
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$245
Incyte Corporation
$241
Eisai Inc.
$238
Gilead Sciences, Inc.
$193
Janssen Biotech, Inc.
$150
Daiichi Sankyo Inc.
$120
Novartis Pharmaceuticals Corporation
$114
PUMA BIOTECHNOLOGY, INC.
$110
Merck Sharp & Dohme LLC
$106
EMD Serono, Inc.
$83
ABBVIE INC.
$80
SpringWorks Therapeutics, Inc.
$79
Celgene Corporation
$78
Bayer Healthcare Pharmaceuticals Inc.
$72
GENZYME CORPORATION
$68
Astellas Pharma US Inc
$66
SOBI, INC
$64
BeiGene USA, Inc.
$59
Deciphera Pharmaceuticals Inc.
$56
Mirati Therapeutics, Inc.
$55
Verity Pharmaceuticals Inc.
$51
Rigel Pharmaceuticals, Inc.
$49
PharmaEssentia USA Corporation
$48
Alexion Pharmaceuticals, Inc.
$45
PFIZER INC.
$44
Coherus Biosciences Inc.
$44
Ipsen Biopharmaceuticals, Inc
$42
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Exelixis Inc.
$34
E.R. Squibb & Sons, L.L.C.
$34
ADC Therapeutics America, Inc.
$32
Tempus AI, Inc
$29
Karyopharm Therapeutics Inc.
$24
GlaxoSmithKline, LLC.
$24
ACCORD HEALTHCARE, INC.
$24
Lilly USA, LLC
$20
Myriad Genetic Laboratories, Inc.
$20
Agios Pharmaceuticals, Inc.
$20
Geron Corporation
$20
Cumberland Pharmaceuticals, Inc.
$17
JAZZ PHARMACEUTICALS INC.
$16
Top 3 companies account for 24.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$806
AstraZeneca Pharmaceuticals LP
$756
Incyte Corporation
$742
Celgene Corporation
$677
PFIZER INC.
$584
Gilead Sciences, Inc.
$445
Merck Sharp & Dohme LLC
$329
Eisai Inc.
$273
Genentech USA, Inc.
$272
Amgen Inc.
$268
Astellas Pharma US Inc
$254
Bayer Healthcare Pharmaceuticals Inc.
$233
Daiichi Sankyo Inc.
$230
EISAI INC.
$210
Regeneron Healthcare Solutions, Inc.
$188
Merck Sharp & Dohme Corporation
$177
GENZYME CORPORATION
$173
PUMA BIOTECHNOLOGY, INC.
$169
Novartis Pharmaceuticals Corporation
$167
Exelixis Inc.
$166
BeiGene USA, Inc.
$163
Seagen Inc.
$138
E.R. Squibb & Sons, L.L.C.
$137
EMD Serono, Inc.
$130
Mirati Therapeutics, Inc.
$120
PharmaEssentia USA Corporation
$98
Karyopharm Therapeutics Inc.
$96
Verity Pharmaceuticals Inc.
$96
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
Lilly USA, LLC
$88
Coherus Biosciences Inc.
$87
SOBI, INC
$84
Pharmacyclics LLC, An AbbVie Company
$83
Kite Pharma, Inc.
$81
ABBVIE INC.
$80
Sumitomo Pharma America, Inc.
$80
SpringWorks Therapeutics, Inc.
$79
Bayer HealthCare Pharmaceuticals Inc.
$76
Pharmacyclics LLC, an AbbVie Company
$75
Myovant Sciences Inc.
$75
Deciphera Pharmaceuticals Inc.
$75
Rigel Pharmaceuticals, Inc.
$68
Takeda Pharmaceuticals U.S.A., Inc.
$57
AVEO Pharmaceuticals, Inc.
$57
Ipsen Biopharmaceuticals, Inc
$57
TerSera Therapeutics LLC
$53
Blueprint Medicines Corporation
$50
Acrotech Biopharma LLC
$49
MorphoSys, US Inc.
$46
Alexion Pharmaceuticals, Inc.
$45
Puma Biotechnology, Inc.
$43
Agios Pharmaceuticals, Inc.
$42
GlaxoSmithKline, LLC.
$40
Sobi, Inc
$40
Stemline Therapeutics Inc.
$37
TAIHO ONCOLOGY, INC.
$36
ADC Therapeutics America, Inc.
$32
AMAG Pharmaceuticals, Inc.
$32
Taiho Oncology, Inc.
$32
Tempus AI, Inc
$29
Aveo Pharmaceuticals, Inc.
$28
Johnson & Johnson Health Care Systems Inc.
$25
Mylan Institutional Inc.
$25
ACCORD HEALTHCARE, INC.
$24
Seattle Genetics, Inc.
$23
Jazz Pharmaceuticals Inc.
$23
AbbVie Inc.
$22
AbbVie, Inc.
$22
Myriad Genetic Laboratories, Inc.
$20
Geron Corporation
$20
Helsinn Therapeutics (U.S.), Inc.
$19
ImmunoGen, Inc.
$18
Cumberland Pharmaceuticals, Inc.
$17
Philips Electronics North America Corporation
$17
Epizyme, Inc.,
$17
Foundation Medicine, Inc.
$16
JAZZ PHARMACEUTICALS INC.
$16
Organon LLC
$15
Top 3 companies account for 22.2% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AKYNZEO · AYVAKIT · Avastin · BELEODAQ · BESREMI · BOSULIF · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CAMCEVI · CHANTIX · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Elahere · Enhertu · Erivedge · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PYRUKYND · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · RYTELO · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · Tecentriq · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vitrakvi · XALKORI · XPOVIO · XTANDI · Xospata · Xtandi · ZEPZELCA · ZOLADEX · ZYTIGA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
1,352
Per 100K population
42.7
County median income
$113,702
Nearest hospital
AHMC ANAHEIM REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Maniam is a clinical cardiology specialist, with above-average Medicare volume (top 18% in CA), with low-engagement industry engagement in the top 14% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Maniam experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Maniam performed 924 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maniam receive payments from pharmaceutical companies?
Yes. Dr. Maniam received a total of $10,363 from 78 companies across 489 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maniam's costs compare to other opticians in Anaheim?
Dr. Maniam's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maniam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Anaheim
Browse opticians in Anaheim ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology